Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment - Top-Institutions - MDSpire

Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment

  • By

  • Itamar Averbuch

  • Roi Tschernichovsky

  • Shlomit Yust-Katz

  • Ofer Rotem

  • Dror Limon

  • Noga Kurman

  • Oded Icht

  • Daniel Reinhorn

  • Mor Moskovitz

  • Ekaterina Hanovich

  • Alexandra Benouaich-Amiel

  • Tali Siegal

  • Alona Zer

  • Omer Gal

  • February 7, 2024

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Radiation Oncology
    • Molecular Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Thoracic Oncology
    • Neuro-oncology
    • Immunotherapy
    • Radiation Oncology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Radiation Oncology
    • Translational Research

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Molecular Oncology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Radiation Oncology

Original Source(s)

Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment

  • by Itamar Averbuch, Roi Tschernichovsky, Shlomit Yust-Katz, Ofer Rotem, Dror Limon, Noga Kurman, Oded Icht, Daniel Reinhorn, Mor Moskovitz, Ekaterina Hanovich, Alexandra Benouaich-Amiel, Tali Siegal, Alona Zer, Omer Gal

  • February 7, 2024

Related Content

Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients

Multiple ground-glass nodules after lobectomy for multiple primary lung cancer: a case report

Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report